1. Kumar, S. K. et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia 28, 1122–1128 (2014).
2. National Cancer Institute. Surveillance, Epidemiology, and End Results Program. Cancer Stat Facts: Myeloma. https://seer.cancer.gov/statfacts/html/mulmy.html : (National Cancer Institute, 2017).
3. Howlader, N. et al. SEER Cancer Statistics Review, 1975–2014, https://seer.cancer.gov/csr/1975_2014/ . Table 18.9, Myeloma, SEER Relative Survival (Percent) By Year of Diagnosis, All Races, Males and Females 2017. https://seer.cancer.gov/csr/1975_2014/browse_csr.php?sectionSEL=18&pageSEL=sect_18_table.09.html ; (National Cancer Institute, Bethesda, 2017).
4. Kumar, S. K. et al. Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology. J. Natl Compr. Canc. Netw. 15, 230–269 (2017).
5. Guglielmelli, T. & Palumbo, A. Multiple myeloma: is a shift toward continuous therapy needed to move forward? Expert Rev. Hematol. 8, 253–256 (2015).